The binding of heparin causes a conformational change in antithrombin
to give an increased heparin binding affinity and activate the inhibit
ion of thrombin and factor Xa. The areas of antithrombin involved in b
inding heparin and stabilizing the interaction in the high-affinity fo
rm have been partially resolved through the study of both recombinant
and natural variants. The role of a section of the N-terminal segment
of antithrombin, residues 22-46 (segment 22-46), in heparin binding wa
s investigated using rapid kinetic analysis of the protein cleaved at
residues 29-30 by limited proteolysis with thermolysin. The cleaved an
tithrombin had 5.5-fold lowered affinity for heparin pentasaccharide a
nd 1.8-fold for full-length, high-affinity heparin. It was shown that,
although the initial binding of heparin is slightly enhanced by the c
leavage, it dissociates much faster from the cleaved form, giving rise
to the overall decrease in heparin affinity. This implies that the se
gment constituting residues 22-46 in the N terminus of antithrombin hi
nders access to the binding site for heparin, hence the increased init
ial binding for the cleaved form, whereas, when heparin is bound, segm
ent 22-46 is involved in the stabilization of the binding interaction,
as indicated by the increased dissociation constant. When the heparin
pentasaccharide is bound to antithrombin prior to incubation with the
rmolysin, it protects the N-terminal cleavage site, implying that segm
ent 22-46 moves to interact with heparin in the conformational change
and thus stabilizes the complex.